SEC Form 4 · accession 0001127602-19-008809

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2019

Accepted (ET)

Feb 28, 2019 · 9:52 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2019	S	100	$140.36	D	290,015	D
Common Stock	Feb 26, 2019	S	85	$140.37	D	289,930	D
Common Stock	Feb 26, 2019	S	100	$140.38	D	289,830	D
Common Stock	Feb 26, 2019	S	300	$140.40	D	289,530	D
Common Stock	Feb 26, 2019	S	7	$140.405	D	289,523	D
Common Stock	Feb 26, 2019	S	100	$140.43	D	289,423	D
Common Stock	Feb 26, 2019	S	200	$140.44	D	289,223	D
Common Stock	Feb 26, 2019	S	200	$140.465	D	289,023	D
Common Stock	Feb 26, 2019	S	100	$140.49	D	288,923	D
Common Stock	Feb 26, 2019	S	300	$140.50	D	288,623	D
Common Stock	Feb 26, 2019	S	4	$140.505	D	288,619	D
Common Stock	Feb 26, 2019	S	100	$140.51	D	288,519	D
Common Stock	Feb 26, 2019	S	100	$140.525	D	288,419	D
Common Stock	Feb 26, 2019	S	400	$140.53	D	288,019	D
Common Stock	Feb 26, 2019	S	94	$140.56	D	287,925	D
Common Stock	Feb 26, 2019	S	200	$140.57	D	287,725	D
Common Stock	Feb 26, 2019	S	97	$140.59	D	287,628	D
Common Stock	Feb 26, 2019	S	171	$140.60	D	287,457	D
Common Stock	Feb 26, 2019	S	100	$140.63	D	287,357	D
Common Stock	Feb 26, 2019	S	100	$140.65	D	287,257	D
Common Stock	Feb 26, 2019	S	100	$140.68	D	287,157	D
Common Stock	Feb 26, 2019	S	300	$140.69	D	286,857	D
Common Stock	Feb 26, 2019	S	100	$140.71	D	286,757	D

No Table II lines on this filing.